The FDA approved the pill Nereus (tradipitant) as a new treatment for vomiting caused by motion sickness, with fewer side ...

After a sluggish first half, the drug and biotech sector has staged a recovery over the past two to three months. This ...

Jiangsu Simcere Pharmaceutical Co. Ltd. has identified antibody-drug conjugates (ADCs) comprising antibody or antigen-binding fragments linked to a cytotoxic drug through a linker reported to be ...

SaveHealth reports on eczema medications, detailing various options from topical treatments to advanced therapies for ...

On December 26, Johnson & Johnson (NYSE:JNJ) said it ended a mid-stage study of an experimental drug for patients with ...

The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...

Johnson & Johnson's phase 2b study of a treatment of moderate to severe atopic dermatitis will end early after the results didn't meet its efficacy standards. The company said the results of a planned ...

The sexually transmitted disease has become increasingly resistant to existing antibiotics. By Andrew Jacobs The Food and Drug Administration has approved two new antibiotics for the treatment of ...

What Is Perioral Dermatitis, and Why Does It Happen? "Perioral dermatitis is a common inflammatory skin condition that typically appears as small red bumps or patches around the mouth, nose, or eyes.